iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $130.61 million. The enterprise value is -$21.66 million.
Important Dates
The last earnings date was Thursday, June 26, 2025, before market open.
| Earnings Date | Jun 26, 2025 |
| Ex-Dividend Date | Apr 17, 2025 |
Share Statistics
iHuman has 51.52 million shares outstanding. The number of shares has decreased by -1.27% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.52M |
| Shares Change (YoY) | -1.27% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 71.43% |
| Owned by Institutions (%) | 0.63% |
| Float | 14.72M |
Valuation Ratios
The trailing PE ratio is 9.68.
| PE Ratio | 9.68 |
| Forward PE | n/a |
| PS Ratio | 1.07 |
| Forward PS | n/a |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.07 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.26% and return on invested capital (ROIC) is 5.15%.
| Return on Equity (ROE) | 11.26% |
| Return on Assets (ROA) | 3.46% |
| Return on Invested Capital (ROIC) | 5.15% |
| Return on Capital Employed (ROCE) | 7.99% |
| Revenue Per Employee | $171,094 |
| Profits Per Employee | $19,595 |
| Employee Count | 723 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 15.58 |
Taxes
In the past 12 months, iHuman has paid $1.50 million in taxes.
| Income Tax | 1.50M |
| Effective Tax Rate | 9.60% |
Stock Price Statistics
The stock price has increased by +41.62% in the last 52 weeks. The beta is 0.36, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +41.62% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 60.56 |
| Average Volume (20 Days) | 9,699 |
Short Selling Information
| Short Interest | 15,357 |
| Short Previous Month | 7,629 |
| Short % of Shares Out | 0.09% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, iHuman had revenue of $123.70 million and earned $14.17 million in profits. Earnings per share was $0.26.
| Revenue | 123.70M |
| Gross Profit | 84.86M |
| Operating Income | 10.48M |
| Pretax Income | 23.18M |
| Net Income | 14.17M |
| EBITDA | 12.43M |
| EBIT | 10.48M |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $154.22 million in cash and $1.95 million in debt, giving a net cash position of $152.26 million or $2.96 per share.
| Cash & Cash Equivalents | 154.22M |
| Total Debt | 1.95M |
| Net Cash | 152.26M |
| Net Cash Per Share | $2.96 |
| Equity (Book Value) | 129.68M |
| Book Value Per Share | 2.52 |
| Working Capital | 119.72M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 68.60%, with operating and profit margins of 8.47% and 11.45%.
| Gross Margin | 68.60% |
| Operating Margin | 8.47% |
| Pretax Margin | 12.67% |
| Profit Margin | 11.45% |
| EBITDA Margin | 10.05% |
| EBIT Margin | 8.47% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.09, which amounts to a dividend yield of 3.35%.
| Dividend Per Share | $0.09 |
| Dividend Yield | 3.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 32.46% |
| Buyback Yield | 1.27% |
| Shareholder Yield | 4.63% |
| Earnings Yield | 10.85% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iHuman has an Altman Z-Score of 2.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.55 |
| Piotroski F-Score | 3 |
